Paolo Gisondi to Adalimumab
This is a "connection" page, showing publications Paolo Gisondi has written about Adalimumab.
Connection Strength
0.284
-
Hidradenitis suppurativa and adalimumab in the COVID-19 era. Eur J Dermatol. 2020 Dec 01; 30(6):748-749.
Score: 0.161
-
Adalimumab is a safe option for psoriasis patients with concomitant hepatitis B or C infection: a multicentre cohort study of 37 patients and review of the literature. J Eur Acad Dermatol Venereol. 2017 Nov; 31(11):1853-1859.
Score: 0.124